Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Eosinophilic Esophagitis: What Works, What Doesn't?
Several treatment options improve symptoms. Which one doesn't?
Eosinophilic esophagitis is diagnosed in a 32-year-old man. He inquires about treatments to help control his dysphagia and reduce his episodes of food impaction. All of the following are treatment options to improve his symptoms, except . . .
a. Mast cell inhibitors
b. Topical corticosteroids
c. Specialized elimination diet
d. Endoscopic dilation
Related Videos
Related Content
Clinical Tips for Using Antibiotics and Corticosteroids in IBD
January 5th 2013Podcast
The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.
